31 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp00570 | [L9]-P18 | KWKLFKKILKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 3 µM |
| dbacp00618 | [S9]-P18 | KWKLFKKISKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 4 µM |
| dbacp02113 | C-1 | KWKLFKKIPFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 26 µM |
| dbacp02116 | C-10 | KWKLFKKIPKFLH | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02119 | C-2 | KWKLFKKIPKFLHLAKK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 38 µM |
| dbacp02122 | C-3 | KWKLFKKIPLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 79 µM |
| dbacp02125 | C-4 | KWKLFKKIPKFLHLAK | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 54 µM |
| dbacp02128 | C-5 | KWKLFKKIPHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 100 µM |
| dbacp02131 | C-6 | KWKLFKKIPKFLHLA | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 47 µM |
| dbacp02134 | C-7 | KWKLFKKIPLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02137 | C-8 | KWKLFKKIPKFLHL | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 83 µM |
| dbacp02140 | C-9 | KWKLFKKIPLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : <100 µM |
| dbacp02234 | CA-MA | KWKLFKKIGIGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 44 µM |
| dbacp02238 | CA-MA-P | KWKLFKKIPKFLHSAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 20 µM |
| dbacp02244 | CA-MA1 | KWKLFKKIKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 100 µM |
| dbacp02248 | CA-MA2 | KWKLFKKIPKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 28 µM |
| dbacp02252 | CA-MA3 | KWKLFKKIGPGKFLHSAKKF | Ceropin-African clawed frog hybrid peptides | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : >100 µM |
| dbacp02749 | Di-PST13-RK-C | KKKFPWWWPFKKKCKKKFPWWWPFKKKC | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 17 µg/ml |
| dbacp02751 | Di-PST13-RK-K | KKKFPWWWPFKKKKKKFPWWWPFKKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 10 µg/ml |
| dbacp04730 | N-1 | WKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 9.5 µM |
| dbacp04733 | N-2 | FKLFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 11 µM |
| dbacp04736 | N-3 | KWFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 17 µM |
| dbacp04739 | N-3L | WFKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04742 | N-4 | WFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 32 µM |
| dbacp04745 | N-4L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 5 µM |
| dbacp04748 | N-5 | WKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : < 100 µM |
| dbacp04751 | N-5L | WKKIPKFLHLLKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 :17 µM |
| dbacp05048 | P18 | KWKFKKIPKFLHLAKKF | Ceropin A | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 8 µM |
| dbacp05695 | PST13-RK | KKKFPWWWPFKKK | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 80 µg/ml |
| dbacp06350 | Tritrpticin | VRRFPWWWPFLRR | Derivative of tritrpticin | Cell membrane disintegration | MTT/MTS assay | MDA-MB-361 | Breast cancer | IC50 : 142 µg/ml |
| dbacp06774 | PMAP-NC | RIIDRLWLVRRPQKPKFVLVWVL | Synthetic Analgog of PMAP-23 | Membrane permeabilization | MTT assay | MDA-MB-361 | Breast Cancer | IC50 = 6.4 μM |